Stay updated on HEC585 Safety & PK in Healthy Subjects Clinical Trial
Sign up to get notified when there's something new on the HEC585 Safety & PK in Healthy Subjects Clinical Trial page.

Latest updates to the HEC585 Safety & PK in Healthy Subjects Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study descriptions for the idiopathic pulmonary fibrosis treatment drug HEC585 and the addition of a new revision number.SummaryDifference33%
- Check15 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check51 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check72 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check80 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to HEC585 Safety & PK in Healthy Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HEC585 Safety & PK in Healthy Subjects Clinical Trial page.